EOJOAM
GPCR icon

E. Ohman J:or Asset Management’s Structure Therapeutics GPCR Stock Holding History

E. Ohman J:or Asset Management’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$172K Sell
3,212
-1,306
-29% -$57.8K ﹤0.01% 465
2026
Q1 		$218K Hold
4,518
– – 0.01% 471
2025
Q4 		$314K Buy
+4,518
New +$184K 0.01% 467

Other funds holding GPCR

PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
WWM
Wolff Wiese Magana Carslbad, California $217M AUM 47.64% 1-Year Est. Return
AFC
Ares Financial Consulting Calabasas, California $139M AUM

E. Ohman J:or Asset Management's GPCR Position: Q2 2026 in Review

E. Ohman J:or Asset Management reduced its Structure Therapeutics (GPCR) stake by 29% in Q2 2026, selling an estimated $57.8K and leaving 3,212 shares worth $172K. The position accounts for ﹤0.01% of the portfolio, ranked #465.

E. Ohman J:or Asset Management first reported a position in GPCR in Q4 2025 and has held it in 3 quarters since. The position peaked at $314K in Q4 2025. 9 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • E. Ohman J:or Asset Management held 3,212 shares of Structure Therapeutics worth $172K as of Q2 2026.
  • E. Ohman J:or Asset Management sold 1,306 Structure Therapeutics shares in Q2 2026, an estimated $57.8K.
  • Structure Therapeutics made up ﹤0.01% of E. Ohman J:or Asset Management's portfolio in Q2 2026, its #465 holding.
  • E. Ohman J:or Asset Management first reported a position in Structure Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • E. Ohman J:or Asset Management's Structure Therapeutics position peaked at $314K in Q4 2025.
  • 9 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on E. Ohman J:or Asset Management's 13F filing for Q2 2026, filed 10 Jul 2026.